Adhesion Barrier Market size is expected to reach USD 1,307.6 Million in 2032- Emergen Research

The global adhesion barrier market is expected to witness significant growth in the coming years. Adhesion barriers are medical devices that are used to prevent the formation of scar tissue after surgery. These devices are commonly used in abdominal, pelvic, and gynecological surgeries. The use of adhesion barriers can help reduce the risk of post-surgical complications, such as chronic pain and bowel obstruction The global adhesion barrier market size is expected to reach USD 1,307.6 Million in 2032, and register a steady revenue CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research. Adhesion barrier market revenue growth is expected to be driven by factors such as growing number of orthopedic surgeries undertaken globally.

One of the major drivers of the adhesion barrier market is the increasing number of surgical procedures. The rising incidence of chronic diseases, such as cancer and cardiovascular diseases, has led to an increase in surgical procedures. The use of adhesion barriers during surgery can help reduce the risk of complications and improve patient outcomes. In addition, the growing geriatric population and the increasing prevalence of obesity are also contributing to the growth of the market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1785

However, the high cost of adhesion barriers and the lack of awareness about their benefits among patients and healthcare providers are some of the factors restraining the growth of the market. Moreover, the stringent regulatory requirements for medical devices are also hindering the growth of the market. In addition, the availability of alternative treatments for post-surgical complications, such as anti-inflammatory drugs, is also a challenge for the growth of the market.

Despite these challenges, there are several growth factors that are expected to drive the adhesion barrier market in the coming years. For instance, the increasing focus on minimally invasive surgeries is expected to create new opportunities for the market. Minimally invasive surgeries require smaller incisions, which can reduce the risk of adhesion formation. In addition, the development of new adhesion barrier products that are more effective and affordable is expected to drive the growth of the market.

Geographically, North America is the largest market for adhesion barriers, accounting for a significant share of the global market. This is primarily due to the high number of surgical procedures in the region and the presence of key players in the market. Europe is also a significant market for adhesion barriers, with countries such as Germany and the UK contributing to the growth of the market. The Asia Pacific region is expected to witness significant growth in the coming years, due to the increasing number of surgical procedures and the growing awareness about the benefits of adhesion barriers.

Overall, the adhesion barrier market is expected to witness significant growth in the coming years, driven by the increasing number of surgical procedures and the development of new and effective adhesion barrier products. However, the high cost of these products and the lack of awareness about their benefits are some of the challenges that need to be addressed to fully realize the potential of the market.

Major Companies and Competitive Landscape:

The global adhesion barrier market is highly competitive, with several key players operating in the market. Some of the leading players in the market include Gunze Medical Japan, Gunze developed its absorbable adhesion barrier by leveraging distinct absorbable material technology with the aim of providing a cutting-edge solution in this field. These players are adopting various strategies, such as product launches, partnerships, and acquisitions, to expand their market presence and enhance their product offerings. For instance, in January 2021, Baxter International Inc. announced the launch of its new adhesion barrier, called DYNAPACK, in Europe. The product is designed to reduce the risk of post-surgical adhesions in patients undergoing abdominal and pelvic surgeries.

Similarly, in December 2020, Sanofi S.A. announced that it had entered into an agreement to acquire Kymab, a clinical-stage biopharmaceutical company that specializes in the development of monoclonal antibody therapies. The acquisition is expected to enhance Sanofi's product portfolio in the field of immunology and inflammation, which includes adhesion barriers.

In addition, several companies are focusing on the development of new and innovative adhesion barrier products. For instance, in February 2021, Anika Therapeutics Inc. announced that it had received CE mark approval for its new adhesion barrier, called HYALOFAST. The product is designed to prevent the formation of scar tissue after surgery and is made from a biocompatible material that is resorbed by the body over time.

Furthermore, companies are also focusing on expanding their geographic presence by entering into new markets. For instance, in February 2021, MAST Biosurgery AG announced that it had received approval from the Chinese National Medical Products Administration (NMPA) for its adhesion barrier product, called COSEAL. The product is designed to reduce the risk of adhesion formation after surgery and is made from a synthetic polymer.

Overall, the adhesion barrier market is highly competitive, with several key players operating in the market. These players are adopting various strategies, such as product launches, partnerships, and acquisitions, to enhance their market presence and expand their product offerings. In addition, the development of new and innovative adhesion barrier products is expected to drive the growth of the market in the coming years.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1785

Segmentation Insights for Adhesion barrier market Report:

The global adhesion barrier market has been segmented by Emergen Research based on type, delivery mode, application, and region. On the basis of type, the market is divided into synthetic adhesion barriers, including hyaluronic acid, regenerated cellulose, polyethylene glycol, and others, and natural adhesion barriers, including collagen and protein and fibrin. By delivery mode, the market is segmented into film formulations, gel formulations, and liquid formulations. The application segment is further classified into gynecological surgeries, general/abdominal surgeries, orthopedic surgeries, cardiovascular surgeries, neurological surgeries, urological surgeries, reconstructive surgeries, and others.

In terms of region, the global adhesion barrier market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market owing to increasing investments in healthcare and the rising prevalence of chronic diseases. Europe is also anticipated to witness significant growth due to the growing number of surgeries and the increasing demand for advanced surgical products. The Asia Pacific region is expected to register significant growth due to increasing awareness about adhesion barriers, growing healthcare expenditure, and rising disposable income in the region.

The synthetic adhesion barrier segment is expected to dominate the market owing to its advantages, including ease of use and cost-effectiveness. The hyaluronic acid sub-segment is expected to hold the largest market share due to its biocompatibility and versatility. The natural adhesion barrier segment is also anticipated to grow significantly due to its effectiveness in reducing post-surgical complications and infection rates.

The film formulations segment is expected to hold the largest market share due to their high efficacy in preventing adhesion formation. The gynecological surgeries segment is expected to dominate the market due to the high incidence of gynecological disorders and an increasing number of gynecological surgeries. The orthopedic surgeries segment is also anticipated to witness significant growth due to the rising incidence of orthopedic disorders and the increasing geriatric population.

The global adhesion barrier market is highly competitive, with several major players operating in the market. The key players in the market include Baxter International Inc., Integra LifeSciences Holdings Corporation, Anika Therapeutics, Inc., FzioMed, Inc., Sanofi, Johnson & Johnson, C.R. Bard, Inc., Medtronic plc, Betatech Medical, and Atrium Medical Corporation. These companies are focusing on strategies such as mergers and acquisitions, collaborations, and partnerships to expand their product portfolio and increase their market share.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/adhesion-barrier-market

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients make smarter business decisions.

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

This release was published on openPR.